Candel Therapeutics, Inc 10-Q for FY2022 Q3
Candel Therapeutics, Inc. (CADL)
10-Q
2022-11-10
For: 2022-09-30
View Original
Added on
April 10, 2026
About this 10-Q
Candel Therapeutics, Inc filed this 10-Q on November 10, 2022, covering the quarter ended September 30, 2022 (FY2022 Q3).
Headline figures
Quarter ended September 30, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $31K
- unchanged from $31K a year earlier
- Net loss
- $8.69M
- compared with a net loss of $16.16M a year earlier
- Diluted EPS
- -$0.30
- compared with -$0.69 a year earlier